Genetics of glucocorticoid regulation and posttraumatic stress disorder-What do we know?

Neuroscience and Biobehavioral Reviews

Volumn 63, Issue , 2016, Pages 143-157

  Castro Vale, Ivone ^a,d   Van Rossum, Elisabeth F C ^b   Machado, José Carlos ^c   Mota Cardoso, Rui ^a   Carvalho, Davide ^a,d  

^a University of Porto   (Portugal)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

AVP oxytocin pathway; FKBP5; Glucocorticoid; Glucocorticoid receptor; HPA axis; PTSD; Single nucleotide polymorphism; Trauma; Vulnerability

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; GLUCOCORTICOID RECEPTOR; OXYTOCIN; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; GLUCOCORTICOID; HYDROCORTISONE; NR3C1 PROTEIN, HUMAN; TACROLIMUS BINDING PROTEIN 5;

5' UNTRANSLATED REGION; CONFORMATIONAL TRANSITION; CRHR1 GENE; DISEASE SEVERITY; FKBP5 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GR GENE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEMORY CONSOLIDATION; NONHUMAN; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BRAIN; FEMALE; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; METABOLISM;

BRAIN; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GLUCOCORTICOID; STRESS DISORDERS, POST-TRAUMATIC; TACROLIMUS BINDING PROTEINS;

EID: 84958257703     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.02.005     Document Type: Review

References (221)

1. Ackermann S., Heck A., Rasch B., Papassotiropoulos A., de Quervain D.J. The BclI polymorphism of the glucocorticoid receptor gene is associated with emotional memory performance in healthy individuals. Psychoneuroendocrinology 2013, 38:1203-1207.
2. Aerni A., Traber R., Hock C., Roozendaal B., Schelling G., Papassotiropoulos A., Nitsch R.M., Schnyder U., de Quervain D.J. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am. J. Psychiatry 2004, 161:1488-1490.
3. Aliczki M., Zelena D., Mikics E., Varga Z.K., Pinter O., Bakos N.V., Varga J., Haller J. Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels: anxiety and locomotor activity in male CD1 mice. Horm. Behav. 2013, 63:752-758.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association Arlington, VA. 5th ed.
5. Amstadter A.B., Nugent N.R., Yang B.Z., Miller A., Siburian R., Moorjani P., Haddad S., Basu A., Fagerness J., Saxe G., Smoller J.W., Koenen K.C. Corticotrophin-releasing hormone type 1 receptor gene (CRHR1) variants predict posttraumatic stress disorder onset and course in pediatric injury patients. Dis. Markers 2011, 30:89-99.
6. Andero R., Ressler K.J. Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav. 2012, 11:503-512.
7. Armour C., Carragher N., Elhai J.D. Assessing the fit of the dysphoric arousal model across two nationally representative epidemiological surveys: the Australian NSMHWB and the United States NESARC. J. Anxiety Disord. 2013, 27:109-115.
8. Ashley-Koch A.E., Garrett M.E., Gibson J., Liu Y., Dennis M.F., Kimbrel N.A., Veterans Affairs Mid-Atlantic Mental Illness Research E., Clinical Center W, Beckham J.C., Hauser M.A. Genome-wide association study of posttraumatic stress disorder in a cohort of Iraq-Afghanistan era veterans. J. Affect. Disord. 2015, 184:225-234.
9. Atsak P., Roozendaal B., Campolongo P. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 2012, 204:104-116.
10. Ayroldi E., Riccardi C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 2009, 23:3649-3658.
11. Bachmann A.W., Sedgley T.L., Jackson R.V., Gibson J.N., Young R.M., Torpy D.J. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 2005, 30:297-306.
12. Bailey J.N., Goenjian A.K., Noble E.P., Walling D.P., Ritchie T., Goenjian H.A. PTSD and dopaminergic genes DRD2 and DAT, in multigenerational families exposed to the Spitak earthquake. Psychiatry Res. 2010, 178:507-510.
13. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., Bruce A.B., Orth D.N., Geracioti T.D. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am. J. Psychiatry 1999, 156:585-588.
14. Baker D.G., Nievergelt C.M., O'Connor D.T. Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 2012, 62:663-673.
15. Binder E.B. The role of FKBP5: a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S186-S195.
16. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., Papiol S., Seaman S., Lucae S., Kohli M.A., Nickel T., Kunzel H.E., Fuchs B., Majer M., Pfennig A., Kern N., Brunner J., Modell S., Baghai T., Deiml T., Zill P., Bondy B., Rupprecht R., Messer T., Kohnlein O., Dabitz H., Bruckl T., Muller N., Pfister H., Lieb R., Mueller J.C., Lohmussaar E., Strom T.M., Bettecken T., Meitinger T., Uhr M., Rein T., Holsboer F., Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 2004, 36:1319-1325.
17. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., Tang Y., Gillespie C.F., Heim C.M., Nemeroff C.B., Schwartz A.C., Cubells J.F., Ressler K.J. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
18. Bomyea J., Risbrough V., Lang A.J. A consideration of select pre-trauma factors as key vulnerabilities in PTSD. Clin. Psychol. Rev. 2012, 32:630-641.
19. Bonanno G.A., Mancini A.D., Horton J.L., Powell T.M., Leardmann C.A., Boyko E.J., Wells T.S., Hooper T.I., Gackstetter G.D., Smith T.C., Millennium Cohort Study T Trajectories of trauma symptoms and resilience in deployed U.S. military service members: prospective cohort study. Br. J. Psychiatry 2012, 200:317-323.
20. Boscarino J.A., Erlich P.M., Hoffman S.N., Zhang X. Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr. Dis. Treat. 2012, 8:131-139.
21. Breen M.S., Maihofer A.X., Glatt S.J., Tylee D.S., Chandler S.D., Tsuang M.T., Risbrough V.B., Baker D.G., O'Connor D.T., Nievergelt C.M., Woelk C.H. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol. Psychiatry 2015, 20:1538-1545.
22. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., Nemeroff C.B., Charney D.S. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 1997, 154:624-629.
23. Breslau N., Kessler R.C., Chilcoat H.D., Schultz L.R., Davis G.C., Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch. Gen. Psychiatry 1998, 55:626-632.
24. Brudey C., Park J., Wiaderkiewicz J., Kobayashi I., Mellman T., Marvar P. Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2015, 309:R315-R321.
25. Bryant R.A., Nickerson A., Creamer M., O'Donnell M., Forbes D., Galatzer-Levy I., McFarlane A.C., Silove D. Trajectory of post-traumatic stress following traumatic injury: 6-year follow-up. Br. J. Psychiatry 2015, 206:417-423.
26. Campolongo P., Roozendaal B., Trezza V., Hauer D., Schelling G., McGaugh J.L., Cuomo V. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4888-4893.
27. Cao-Lei L., Leija S.C., Kumsta R., Wust S., Meyer J., Turner J.D., Muller C.P. Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions. Hum. Genet. 2011, 129:533-543.
28. Cohen H., Kozlovsky N., Alona C., Matar M.A., Joseph Z. Animal model for PTSD: from clinical concept to translational research. Neuropharmacology 2012, 62:715-724.
29. Cornelius J.R., Kirisci L., Reynolds M., Clark D.B., Hayes J., Tarter R. PTSD contributes to teen and young adult cannabis use disorders. Addict. Behav. 2010, 35:91-94.
30. Creamer M., Burgess P., McFarlane A.C. Post-traumatic stress disorder: findings from the Australian national survey of mental health and well-being. Psychol. Med. 2001, 31:1237-1247.
31. Cross-Disorder Group of the Psychiatric Genomics C Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
32. Daskalakis N.P., Bagot R.C., Parker K.J., Vinkers C.H., de Kloet E.R. The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome. Psychoneuroendocrinology 2013, 38:1858-1873.
33. Daskalakis N.P., Lehrner A., Yehuda R. Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment. Endocrinol. Metab. Clin. North Am. 2013, 42:503-513.
34. Daskalakis N.P., Cohen H., Cai G., Buxbaum J.D., Yehuda R. Expression profiling associates blood and brain glucocorticoid receptor signaling with trauma-related individual differences in both sexes. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:13529-13534.
35. Davidson J.R. Surviving disaster: what comes after the trauma?. Br. J. Psychiatry 2002, 181:366-368.
36. Davis M. The role of the amygdala in conditioned and unconditioned fear and anxiety. The Amygdala. A Functional Analysis 2000, 213-287. Oxford University Press, New York. second ed. J.P. Aggleton (Ed.).
37. de Bitencourt R.M., Pamplona F.A., Takahashi R.N. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers. Neuropharmacology 2013, 64:389-395.
38. de Kloet E.R. From receptor balance to rational glucocorticoid therapy. Endocrinology 2014, 155:2754-2769.
39. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
40. de Kloet C.S., Vermetten E., Geuze E., Kavelaars A., Heijnen C.J., Westenberg H.G. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J. Psychiatr. Res. 2006, 40:550-567.
41. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., Westenberg H.G., Heijnen C.J. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol. Psychiatry 2007, 12:443-453.
42. de Quervain D.J., Aerni A., Roozendaal B. Preventive effect of beta-adrenoceptor blockade on glucocorticoid-induced memory retrieval deficits. Am. J. Psychiatry 2007, 164:967-969.
43. de Quervain D.J., Aerni A., Schelling G., Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Front. Neuroendocrinol. 2009, 30:358-370.
44. Derijk R.H., Schaaf M.J., Turner G., Datson N.A., Vreugdenhil E., Cidlowski J., de Kloet E.R., Emery P., Sternberg E.M., Detera-Wadleigh S.D. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 2001, 28:2383-2388.
45. Derijk R.H., van Leeuwen N., Klok M.D., Zitman F.G. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur. J. Pharmacol. 2008, 585:492-501.
46. DiGangi J., Guffanti G., McLaughlin K.A., Koenen K.C. Considering trauma exposure in the context of genetics studies of posttraumatic stress disorder: a systematic review. Biol. Mood Anxiety Disord. 2013, 3:2.
47. Dragan W.L., Oniszczenko W. The association between dopamine D4 receptor exon III polymorphism and intensity of PTSD symptoms among flood survivors. Anxiety Stress Coping 2009, 22:483-495.
48. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 2:986-989.
49. Ehring T., Ehlers A., Cleare A.J., Glucksman E. Do acute psychological and psychobiological responses to trauma predict subsequent symptom severities of PTSD and depression?. Psychiatry Res. 2008, 161:67-75.
50. Elhai J.D., Biehn T.L., Armour C., Klopper J.J., Frueh B.C., Palmieri P.A. Evidence for a unique PTSD construct represented by PTSD's D1-D3 symptoms. J. Anxiety Disord. 2011, 25:340-345.
51. Encio I.J., Detera-Wadleigh S.D. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 1991, 266:7182-7188.
52. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
53. Feldman R., Vengrober A., Ebstein R.P. Affiliation buffers stress: cumulative genetic risk in oxytocin-vasopressin genes combines with early caregiving to predict PTSD in war-exposed young children. Transl. Psychiatry 2014, 4:e370.
54. Galatzer-Levy I.R., Madan A., Neylan T.C., Henn-Haase C., Marmar C.R. Peritraumatic and trait dissociation differentiate police officers with resilient versus symptomatic trajectories of posttraumatic stress symptoms. J. Trauma. Stress 2011, 24:557-565.
55. Galatzer-Levy I.R., Steenkamp M.M., Brown A.D., Qian M., Inslicht S., Henn-Haase C., Otte C., Yehuda R., Neylan T.C., Marmar C.R. Cortisol response to an experimental stress paradigm prospectively predicts long-term distress and resilience trajectories in response to active police service. J. Psychiatr. Res. 2014, 56:36-42.
56. Geerling J.C., Loewy A.D. Aldosterone in the brain. Am. J. Physiol. Renal Physiol. 2009, 297:F559-F576.
57. Gill J.M., Saligan L., Woods S., Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect. Psychiatr. Care 2009, 45:262-277.
58. Glatt S.J., Tylee D.S., Chandler S.D., Pazol J., Nievergelt C.M., Woelk C.H., Baker D.G., Lohr J.B., Kremen W.S., Litz B.T., Tsuang M.T., Marine Resiliency Study I. Blood-based gene-expression predictors of PTSD risk and resilience among deployed marines: a pilot study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013, 162B:313-326.
59. Gola H., Engler A., Morath J., Adenauer H., Elbert T., Kolassa I.T., Engler H. Reduced peripheral expression of the glucocorticoid receptor alpha isoform in individuals with posttraumatic stress disorder: a cumulative effect of trauma burden. PLoS One 2014, 9:e86333.
60. Goshen I., Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front. Neuroendocrinol. 2009, 30:30-45.
61. Goto Y., Otani S., Grace A.A. The Yin and Yang of dopamine release: a new perspective. Neuropharmacology 2007, 53:583-587.
62. Gotovac K., Sabioncello A., Rabatic S., Berki T., Dekaris D. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin. Exp. Immunol. 2003, 131:335-339.
63. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell. Endocrinol. 2007, 275:2-12.
64. Guffanti G., Galea S., Yan L., Roberts A.L., Solovieff N., Aiello A.E., Smoller J.W., De Vivo I., Ranu H., Uddin M., Wildman D.E., Purcell S., Koenen K.C. Genome-wide association study implicates a novel RNA gene, the lincRNA AC068718.1, as a risk factor for post-traumatic stress disorder in women. Psychoneuroendocrinology 2013, 38:3029-3038.
65. Hapke U., Schumann A., Rumpf H.J., John U., Meyer C. Post-traumatic stress disorder: the role of trauma, pre-existing psychiatric disorders, and gender. Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256:299-306.
66. Harpaz-Rotem I., Tsai J., Pietrzak R.H., Hoff R. The dimensional structure of posttraumatic stress symptomatology in 323,903 U.S. veterans. J. Psychiatr. Res. 2014, 49:31-36.
67. Hartmann J., Wagner K.V., Liebl C., Scharf S.H., Wang X.D., Wolf M., Hausch F., Rein T., Schmidt U., Touma C., Cheung-Flynn J., Cox M.B., Smith D.F., Holsboer F., Muller M.B., Schmidt M.V. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 2012, 62:332-339.
68. Hauer D., Weis F., Papassotiropoulos A., Schmoeckel M., Beiras-Fernandez A., Lieke J., Kaufmann I., Kirchhoff F., Vogeser M., Roozendaal B., Briegel J., de Quervain D., Schelling G. Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit. Care Med. 2011, 39:643-650.
69. Hauer D., Kolassa I.T., Laubender R.P., Mansmann U., Hagl C., Roozendaal B., de Quervain D.J., Schelling G. A genotype-specific, randomized controlled behavioral intervention to improve the neuroemotional outcome of cardiac surgery: study protocol for a randomized controlled trial. Trials 2013, 14:89.
70. Hauer D., Schelling G., Gola H., Campolongo P., Morath J., Roozendaal B., Hamuni G., Karabatsiakis A., Atsak P., Vogeser M., Kolassa I.T. Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One 2013, 8:e62741.
71. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr. 2009, 14:13-24.
72. Henley D.E., Lightman S.L. New insights into corticosteroid-binding globulin and glucocorticoid delivery. Neuroscience 2011, 180:1-8.
73. Hill M.N., McEwen B.S. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:791-797.
74. Hill M.N., Bierer L.M., Makotkine I., Golier J.A., Galea S., McEwen B.S., Hillard C.J., Yehuda R. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology 2013, 38:2952-2961.
75. Holmes M.C., Seckl J.R. The role of 11beta-hydroxysteroid dehydrogenases in the brain. Mol. Cell. Endocrinol. 2006, 248:9-14.
76. Holsboer F., Ising M. Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 2010, 61:81-109. C101-C111.
77. Horn C.A., Pietrzak R.H., Corsi-Travali S., Neumeister A. Linking plasma cortisol levels to phenotypic heterogeneity of posttraumatic stress symptomatology. Psychoneuroendocrinology 2014, 39:88-93.
78. Huizenga N.A., Koper J.W., De Lange P., Pols H.A., Stolk R.P., Burger H., Grobbee D.E., Brinkmann A.O., De Jong F.H., Lamberts S.W. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab. 1998, 83:144-151.
79. Joels M., Pasricha N., Karst H. The interplay between rapid and slow corticosteroid actions in brain. Eur. J. Pharmacol. 2013, 719:44-52.
80. Johnson L.R., Farb C., Morrison J.H., McEwen B.S., LeDoux J.E. Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience 2005, 136:289-299.
81. Kadmiel M., Cidlowski J.A. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol. Sci. 2013, 34:518-530.
82. Kehle S.M., Reddy M.K., Ferrier-Auerbach A.G., Erbes C.R., Arbisi P.A., Polusny M.A. Psychiatric diagnoses, comorbidity, and functioning in National Guard troops deployed to Iraq. J. Psychiatr. Res. 2011, 45:126-132.
83. Klaassens E.R., Giltay E.J., Cuijpers P., van Veen T., Zitman F.G. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis. Psychoneuroendocrinology 2012, 37:317-331.
84. Klengel T., Mehta D., Anacker C., Rex-Haffner M., Pruessner J.C., Pariante C.M., Pace T.W., Mercer K.B., Mayberg H.S., Bradley B., Nemeroff C.B., Holsboer F., Heim C.M., Ressler K.J., Rein T., Binder E.B. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 2013, 16:33-41.
85. Kolassa I.T., Kolassa S., Ertl V., Papassotiropoulos A., De Quervain D.J. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158) met polymorphism. Biol. Psychiatry 2010, 67:304-308.
86. Koper J.W., Stolk R.P., de Lange P., Huizenga N.A., Molijn G.J., Pols H.A., Grobbee D.E., Karl M., de Jong F.H., Brinkmann A.O., Lamberts S.W. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum. Genet. 1997, 99:663-668.
87. Kornfeld J.W., Grebien F., Kerenyi M.A., Friedbichler K., Kovacic B., Zankl B., Hoelbl A., Nivarti H., Beug H., Sexl V., Muller M., Kenner L., Mullner E.W., Gouilleux F., Moriggl R. The different functions of Stat5 and chromatin alteration through Stat5 proteins. Front. Biosci. 2008, 13:6237-6254.
88. Krauseneck T., Padberg F., Roozendaal B., Grathwohl M., Weis F., Hauer D., Kaufmann I., Schmoeckel M., Schelling G. A beta-adrenergic antagonist reduces traumatic memories and PTSD symptoms in female but not in male patients after cardiac surgery. Psychol. Med. 2010, 40:861-869.
89. Kumsta R., Entringer S., Koper J.W., van Rossum E.F., Hellhammer D.H., Wust S. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol. Psychiatry 2007, 62:863-869.
90. Kumsta R., Entringer S., Koper J.W., van Rossum E.F., Hellhammer D.H., Wust S. Working memory performance is associated with common glucocorticoid receptor gene polymorphisms. Neuropsychobiology 2010, 61:49-56.
91. Labonte B., Azoulay N., Yerko V., Turecki G., Brunet A. Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder. Transl. Psychiatry 2014, 4:e368.
92. Levy-Gigi E., Szabo C., Kelemen O., Keri S. Association among clinical response, hippocampal volume, and FKBP5 gene expression in individuals with posttraumatic stress disorder receiving cognitive behavioral therapy. Biol. Psychiatry 2013, 74:793-800.
93. Li J., Soroka J., Buchner J. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones. Biochim. Biophys. Acta 2012, 1823:624-635.
94. Liberzon I., King A.P., Ressler K.J., Almli L.M., Zhang P., Ma S.T., Cohen G.H., Tamburrino M.B., Calabrese J.R., Galea S. Interaction of the ADRB2 gene polymorphism with childhood trauma in predicting adult symptoms of posttraumatic stress disorder. JAMA Psychiatry 2014, 71:1174-1182.
95. Liposits Z., Bohn M.C. Association of glucocorticoid receptor immunoreactivity with cell membrane and transport vesicles in hippocampal and hypothalamic neurons of the rat. J. Neurosci. Res. 1993, 35:14-19.
96. Logue M.W., Baldwin C., Guffanti G., Melista E., Wolf E.J., Reardon A.F., Uddin M., Wildman D., Galea S., Koenen K.C., Miller M.W. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol. Psychiatry 2013, 18:937-942.
97. Logue M.W., Smith A.K., Baldwin C., Wolf E.J., Guffanti G., Ratanatharathorn A., Stone A., Schichman S.A., Humphries D., Binder E.B., Arloth J., Menke A., Uddin M., Wildman D., Galea S., Aiello A.E., Koenen K.C., Miller M.W. An analysis of gene expression in PTSD implicates genes involved in the glucocorticoid receptor pathway and neural responses to stress. Psychoneuroendocrinology 2015, 57:1-13.
98. Lu A.T., Ogdie M.N., Jarvelin M.R., Moilanen I.K., Loo S.K., McCracken J.T., McGough J.J., Yang M.H., Peltonen L., Nelson S.F., Cantor R.M., Smalley S.L. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1488-1494.
99. Luca F., Kashyap S., Southard C., Zou M., Witonsky D., Di Rienzo A., Conzen S.D. Adaptive variation regulates the expression of the human SGK1 gene in response to stress. PLoS Genet. 2009, 5:e1000489.
100. Manenschijn L., van den Akker E.L., Lamberts S.W., van Rossum E.F. Clinical features associated with glucocorticoid receptor polymorphisms. Ann. N. Y. Acad. Sci. 2009, 1179:179-198.
101. Manenschijn L., Koper J.W., Lamberts S.W., van Rossum E.F. Evaluation of a method to measure long term cortisol levels. Steroids 2011, 76:1032-1036.
102. Matic G., Milutinovic D.V., Nestorov J., Elakovic I., Jovanovic S.M., Perisic T., Dunderski J., Damjanovic S., Knezevic G., Spiric Z., Vermetten E., Savic D. Lymphocyte glucocorticoid receptor expression level and hormone-binding properties differ between war trauma-exposed men with and without PTSD. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 43:238-245.
103. McFarlane A.C., Barton C.A., Yehuda R., Wittert G. Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology 2011, 36:720-727.
104. McKeever V.M., Huff M.E. A diathesis-stress model of posttraumatic stress disorder: ecological, biological, and residual stress pathways. Rev. Gen. Psychol. 2003, 7:237-250.
105. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br. J. Psychiatry 2007, 191:387-392.
106. Mehta D., Binder E.B. Gene×environment vulnerability factors for PTSD: the HPA-axis. Neuropharmacology 2012, 62:654-662.
107. Mehta D., Gonik M., Klengel T., Rex-Haffner M., Menke A., Rubel J., Mercer K.B., Putz B., Bradley B., Holsboer F., Ressler K.J., Muller-Myhsok B., Binder E.B. Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 2011, 68:901-910.
108. Meyer J.S., Novak M.A. Minireview: hair cortisol: a novel biomarker of hypothalamic-pituitary-adrenocortical activity. Endocrinology 2012, 153:4120-4127.
109. Mizoguchi K., Ishige A., Takeda S., Aburada M., Tabira T. Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J. Neurosci. 2004, 24:5492-5499.
110. Moisan M.P., Minni A.M., Dominguez G., Helbling J.C., Foury A., Henkous N., Dorey R., Beracochea D. Role of corticosteroid binding globulin in the fast actions of glucocorticoids on the brain. Steroids 2014, 81:109-115.
111. Morris M.C., Compas B.E., Garber J. Relations among posttraumatic stress disorder comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin. Psychol. Rev. 2012, 32:301-315.
112. Naifeh J.A., North T.C., Davis J.L., Reyes G., Logan C.A., Elhai J.D. Clinical profile differences between PTSD-diagnosed military veterans and crime victims. J. Trauma. Dissociation 2008, 9:321-334.
113. Nair S.C., Rimerman R.A., Toran E.J., Chen S., Prapapanich V., Butts R.N., Smith D.F. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol. Cell. Biol. 1997, 17:594-603.
114. Nederhof E., Schmidt M.V. Mismatch or cumulative stress: toward an integrated hypothesis of programming effects. Physiol. Behav. 2012, 106:691-700.
115. Neumeister A., Normandin M.D., Pietrzak R.H., Piomelli D., Zheng M.Q., Gujarro-Anton A., Potenza M.N., Bailey C.R., Lin S.F., Najafzadeh S., Ropchan J., Henry S., Corsi-Travali S., Carson R.E., Huang Y. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol. Psychiatry 2013, 18:1034-1040.
116. Neumeister A., Seidel J., Ragen B.J., Pietrzak R.H. Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder. Psychoneuroendocrinology 2015, 51C:577-584.
117. Neylan T.C., Sun B., Rempel H., Ross J., Lenoci M., O'Donovan A., Pulliam L. Suppressed monocyte gene expression profile in men versus women with PTSD. Brain Behav. Immun. 2011, 25:524-531.
118. Nievergelt C.M., Maihofer A.X., Mustapic M., Yurgil K.A., Schork N.J., Miller M.W., Logue M.W., Geyer M.A., Risbrough V.B., O'Connor D.T., Baker D.G. Genomic predictors of combat stress vulnerability and resilience in U.S. marines: a genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology 2015, 51:459-471.
119. Nishi M., Kawata M. Dynamics of glucocorticoid receptor and mineralocorticoid receptor: implications from live cell imaging studies. Neuroendocrinology 2007, 85:186-192.
120. Norris F.H., Murphy A.D., Baker C.K., Perilla J.L., Rodriguez F.G., Rodriguez Jde J. Epidemiology of trauma and posttraumatic stress disorder in Mexico. J. Abnorm. Psychol. 2003, 112:646-656.
121. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 2011, 286:3177-3184.
122. Oakley R.H., Cidlowski J.A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 2013, 132:1033-1044.
123. Ouyang M., Young M.B., Lestini M.M., Schutsky K., Thomas S.A. Redundant catecholamine signaling consolidates fear memory via phospholipase C. J. Neurosci. 2012, 32:1932-1941.
124. Panarelli M., Holloway C.D., Fraser R., Connell J.M., Ingram M.C., Anderson N.H., Kenyon C.J. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J. Clin. Endocrinol. Metab. 1998, 83:1846-1852.
125. Panksepp J. Emotional endophenotypes in evolutionary psychiatry. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:774-784.
126. Papadimitriou A., Priftis K.N. Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation 2009, 16:265-271.
127. Perroud N., Rutembesa E., Paoloni-Giacobino A., Mutabaruka J., Mutesa L., Stenz L., Malafosse A., Karege F. The Tutsi genocide and transgenerational transmission of maternal stress: epigenetics and biology of the HPA axis. World J. Biol. Psychiatry 2014, 15:334-345.
128. Pietrzak R.H., Tsai J., Harpaz-Rotem I., Whealin J.M., Southwick S.M. Support for a novel five-factor model of posttraumatic stress symptoms in three independent samples of Iraq/Afghanistan veterans: a confirmatory factor analytic study. J. Psychiatr. Res. 2012, 46:317-322.
129. Pietrzak R.H., Henry S., Southwick S.M., Krystal J.H., Neumeister A. Linking in vivo brain serotonin type 1B receptor density to phenotypic heterogeneity of posttraumatic stress symptomatology. Mol. Psychiatry 2013, 18:399-401.
130. Pietrzak R.H., Van Ness P.H., Fried T.R., Galea S., Norris F.H. Trajectories of posttraumatic stress symptomatology in older persons affected by a large-magnitude disaster. J. Psychiatr. Res. 2013, 47:520-526.
131. Pietrzak R.H., Huang Y., Corsi-Travali S., Zheng M.Q., Lin S.F., Henry S., Potenza M.N., Piomelli D., Carson R.E., Neumeister A. Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors. Neuropsychopharmacology 2014, 39:2519-2528.
132. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 1997, 18:306-360.
133. Pujols L., Mullol J., Roca-Ferrer J., Torrego A., Xaubet A., Cidlowski J.A., Picado C. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am. J. Physiol. Cell Physiol. 2002, 283:C1324-C1331.
134. Quax R.A., Manenschijn L., Koper J.W., Hazes J.M., Lamberts S.W., van Rossum E.F., Feelders R.A. Glucocorticoid sensitivity in health and disease. Nat. Rev. Endocrinol. 2013, 9:670-686.
135. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
136. Rasetti R., Weinberger D.R. Intermediate phenotypes in psychiatric disorders. Curr. Opin. Genet. Dev. 2011, 21:340-348.
137. Resnick H.S., Yehuda R., Pitman R.K., Foy D.W. Effect of previous trauma on acute plasma cortisol level following rape. Am. J. Psychiatry 1995, 152:1675-1677.
138. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
139. Roberts C.J., Stuhr K.L., Hutz M.J., Raff H., Hillard C.J. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice. Pharmacol. Biochem. Behav. 2014, 117:17-24.
140. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2010, 35:104-114.
141. Romero E.M., Fernandez B., Sagredo O., Gomez N., Uriguen L., Guaza C., De Miguel R., Ramos J.A., Viveros M.P. Antinociceptive behavioural and neuroendocrine effects of CP 55,940 in young rats. Brain Res. Dev. Brain Res. 2002, 136:85-92.
142. Roozendaal B., Okuda S., de Quervain D.J., McGaugh J.L. Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 2006, 138:901-910.
143. Roozendaal B., Barsegyan A., Lee S. Adrenal stress hormones amygdala activation, and memory for emotionally arousing experiences. Prog. Brain Res. 2008, 167:79-97.
144. Russcher H., Smit P., van den Akker E.L., van Rossum E.F., Brinkmann A.O., de Jong F.H., Lamberts S.W., Koper J.W. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J. Clin. Endocrinol. Metab. 2005, 90:5804-5810.
145. Russcher H., van Rossum E.F., de Jong F.H., Brinkmann A.O., Lamberts S.W., Koper J.W. Increased expression of the glucocorticoid receptor-a translational isoform as a result of the ER22/23EK polymorphism. Mol. Endocrinol. 2005, 19:1687-1696.
146. Rytwinski N.K., Scur M.D., Feeny N.C., Youngstrom E.A. The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J. Trauma. Stress 2013, 26:299-309.
147. Sarapas C., Cai G., Bierer L.M., Golier J.A., Galea S., Ising M., Rein T., Schmeidler J., Muller-Myhsok B., Uhr M., Holsboer F., Buxbaum J.D., Yehuda R. Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis. Markers 2011, 30:101-110.
148. Savic D., Knezevic G., Damjanovic S., Spiric Z., Matic G. The role of personality and traumatic events in cortisol levels-where does PTSD fit in?. Psychoneuroendocrinology 2012, 37:937-947.
149. Savic D., Knezevic G., Damjanovic S., Antic J., Matic G. GR gene BclI polymorphysm changes the path, but not the level, of dexamethasone-induced cortisol suppression. J. Affect. Disord. 2014, 168:1-4.
150. Savory J.G., Prefontaine G.G., Lamprecht C., Liao M., Walther R.F., Lefebvre Y.A., Hache R.J. Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol. Cell. Biol. 2001, 21:781-793.
151. Schelling G., Briegel J., Roozendaal B., Stoll C., Rothenhausler H.B., Kapfhammer H.P. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol. Psychiatry 2001, 50:978-985.
152. Schelling G., Kilger E., Roozendaal B., de Quervain D.J., Briegel J., Dagge A., Rothenhausler H.B., Krauseneck T., Nollert G., Kapfhammer H.P. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol. Psychiatry 2004, 55:627-633.
153. Schmidt U., Wochnik G.M., Rosenhagen M.C., Young J.C., Hartl F.U., Holsboer F., Rein T. Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J. Biol. Chem. 2003, 278:4926-4931.
154. Segman R.H., Cooper-Kazaz R., Macciardi F., Goltser T., Halfon Y., Dobroborski T., Shalev A.Y. Association between the dopamine transporter gene and posttraumatic stress disorder. Mol. Psychiatry 2002, 7:903-907.
155. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol. Psychiatry 2005, 10:500-513. 425.
156. Silverman M.N., Pearce B.D., Biron C.A., Miller A.H. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 2005, 18:41-78.
157. Spijker A.T., van Rossum E.F. Glucocorticoid receptor polymorphisms in major depression. Focus on glucocorticoid sensitivity and neurocognitive functioning. Ann. N. Y. Acad. Sci. 2009, 1179:199-215.
158. Spijker A.T., Staufenbiel S.M., van Rossum E.F. New insights into ways of determining cortisol exposure in patients with bipolar disorder. Tijdschr. Psychiatr. 2014, 56:788-797.
159. Stahn C., Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 2008, 4:525-533.
160. Stankiewicz A.M., Swiergiel A.H., Lisowski P. Epigenetics of stress adaptations in the brain. Brain Res. Bull. 2013, 98:76-92.
161. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 2006, 6:318-328.
162. Steudte S., Kirschbaum C., Gao W., Alexander N., Schonfeld S., Hoyer J., Stalder T. Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol. Psychiatry 2013, 74:639-646.
163. Strawn J.R., Geracioti T.D. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress. Anxiety 2008, 25:260-271.
164. Strickland I., Kisich K., Hauk P.J., Vottero A., Chrousos G.P., Klemm D.J., Leung D.Y. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J. Exp. Med. 2001, 193:585-593.
165. Strohle A., Scheel M., Modell S., Holsboer F. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. J. Psychiatr. Res. 2008, 42:1185-1188.
166. Su T.P., Zhang L., Chung M.Y., Chen Y.S., Bi Y.M., Chou Y.H., Barker J.L., Barrett J.E., Maric D., Li X.X., Li H., Webster M.J., Benedek D., Carlton J.R., Ursano R. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J. Psychiatr. Res. 2009, 43:1078-1085.
167. Tasker J.G., Di S., Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 2006, 147:5549-5556.
168. Touma C., Gassen N.C., Herrmann L., Cheung-Flynn J., Bull D.R., Ionescu I.A., Heinzmann J.M., Knapman A., Siebertz A., Depping A.M., Hartmann J., Hausch F., Schmidt M.V., Holsboer F., Ising M., Cox M.B., Schmidt U., Rein T. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 2011, 70:928-936.
169. Trapp T., Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol. Sci. 1996, 17:145-149.
170. True W.R., Rice J., Eisen S.A., Heath A.C., Goldberg J., Lyons M.J., Nowak J. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch. Gen. Psychiatry 1993, 50:257-264.
171. Turner J.D., Schote A.B., Macedo J.A., Pelascini L.P., Muller C.P. Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?. Biochem. Pharmacol. 2006, 72:1529-1537.
172. Turner J.D., Vernocchi S., Schmitz S., Muller C.P. Role of the 5'-untranslated regions in post-transcriptional regulation of the human glucocorticoid receptor. Biochim. Biophys. Acta 2014, 1839:1051-1061.
173. Tyrka A.R., Price L.H., Gelernter J., Schepker C., Anderson G.M., Carpenter L.L. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol. Psychiatry 2009, 66:681-685.
174. Van Craenenbroeck K., De Bosscher K., Vanden Berghe W., Vanhoenacker P., Haegeman G. Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol. Cell. Endocrinol. 2005, 245:10-22.
175. van Gaalen M.M., Stenzel-Poore M.P., Holsboer F., Steckler T. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur. J. Neurosci. 2002, 15:2007-2015.
176. van Leeuwen N., Kumsta R., Entringer S., de Kloet E.R., Zitman F.G., DeRijk R.H., Wust S. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 2010, 35:339-349.
177. van Leeuwen N., Bellingrath S., de Kloet E.R., Zitman F.G., DeRijk R.H., Kudielka B.M., Wust S. Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response. Psychoneuroendocrinology 2011, 36:699-709.
178. van Rossum E.F., Koper J.W., Huizenga N.A., Uitterlinden A.G., Janssen J.A., Brinkmann A.O., Grobbee D.E., de Jong F.H., van Duyn C.M., Pols H.A., Lamberts S.W. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 2002, 51:3128-3134.
179. van Rossum E.F., Koper J.W., van den Beld A.W., Uitterlinden A.G., Arp P., Ester W., Janssen J.A., Brinkmann A.O., de Jong F.H., Grobbee D.E., Pols H.A., Lamberts S.W. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. (Oxf.) 2003, 59:585-592.
180. van Rossum E.F., Roks P.H., de Jong F.H., Brinkmann A.O., Pols H.A., Koper J.W., Lamberts S.W. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin. Endocrinol. (Oxf.) 2004, 61:573-581.
181. van Rossum E.F., Binder E.B., Majer M., Koper J.W., Ising M., Modell S., Salyakina D., Lamberts S.W., Holsboer F. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol. Psychiatry 2006, 59:681-688.
182. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Heijnen C.J., Kavelaars A. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am. J. Psychiatry 2011, 168:89-96.
183. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Amarouchi K., Kavelaars A., Heijnen C.J. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol. Psychiatry 2012, 71:309-316.
184. van Zuiden M., Heijnen C.J., Maas M., Amarouchi K., Vermetten E., Geuze E., Kavelaars A. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: a prospective study. Psychoneuroendocrinology 2012, 37:1822-1836.
185. van den Akker E.L., Russcher H., van Rossum E.F., Brinkmann A.O., de Jong F.H., Hokken A., Pols H.A., Koper J.W., Lamberts S.W. Glucocorticoid receptor polymorphism affects transrepression but not transactivation. J. Clin. Endocrinol. Metab. 2006, 91:2800-2803.
186. Vermeer H., Hendriks-Stegeman B.I., van der Burg B., van Buul-Offers S.C., Jansen M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab. 2003, 88:277-284.
187. Vernocchi S., Battello N., Schmitz S., Revets D., Billing A.M., Turner J.D., Muller C.P. Membrane glucocorticoid receptor activation induces proteomic changes aligning with classical glucocorticoid effects. Mol. Cell. Proteomics 2013, 12:1764-1779.
188. Vetter S., Rossegger A., Rossler W., Bisson J.I., Endrass J. Exposure to the tsunami disaster, PTSD symptoms and increased substance use-an Internet based survey of male and female residents of Switzerland. BMC Public Health 2008, 8:92.
189. Vidovic A., Vilibic M., Sabioncello A., Gotovac K., Rabatic S., Folnegovic-Smalc V., Dekaris D. Circulating lymphocyte subsets natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder: cross-sectional study. Croat. Med. J. 2007, 48:198-206.
190. Voisey J., Swagell C.D., Hughes I.P., Morris C.P., van Daal A., Noble E.P., Kann B., Heslop K.A., Young R.M., Lawford B.R. The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans. Depress. Anxiety 2009, 26:28-33.
191. Vukojevic V., Kolassa I.T., Fastenrath M., Gschwind L., Spalek K., Milnik A., Heck A., Vogler C., Wilker S., Demougin P., Peter F., Atucha E., Stetak A., Roozendaal B., Elbert T., Papassotiropoulos A., de Quervain D.J. Epigenetic modification of the glucocorticoid receptor gene is linked to traumatic memory and post-traumatic stress disorder risk in genocide survivors. J. Neurosci. 2014, 34:10274-10284.
192. Wahbeh H., Oken B.S. Salivary cortisol lower in posttraumatic stress disorder. J. Trauma. Stress 2013, 26:241-248.
193. Wang L., Cao C., Wang W., Xu H., Zhang J., Deng H., Zhang X. Linking hair cortisol levels to phenotypic heterogeneity of posttraumatic stress symptoms in highly traumatized chinese women. Biol. Psychiatry 2015, 77:e21-22.
194. Wessa M., Rohleder N., Kirschbaum C., Flor H. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 2006, 31:209-215.
195. Whitaker A.M., Gilpin N.W., Edwards S. Animal models of post-traumatic stress disorder and recent neurobiological insights. Behav. Pharmacol. 2014, 25:398-409.
196. White S., Acierno R., Ruggiero K.J., Koenen K.C., Kilpatrick D.G., Galea S., Gelernter J., Williamson V., McMichael O., Vladimirov V.I., Amstadter A.B. Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults. J. Anxiety Disord. 2013, 27:678-683.
197. Wilker S., Pfeiffer A., Kolassa S., Elbert T., Lingenfelder B., Ovuga E., Papassotiropoulos A., de Quervain D., Kolassa I.T. The role of FKBP5 genotype in moderating long-term effectiveness of exposure-based psychotherapy for posttraumatic stress disorder. Transl. Psychiatry 2014, 4:e403.
198. Wolf E.J., Mitchell K.S., Logue M.W., Baldwin C.T., Reardon A.F., Aiello A., Galea S., Koenen K.C., Uddin M., Wildman D., Miller M.W. The dopamine D3 receptor gene and posttraumatic stress disorder. J. Trauma. Stress 2014, 27:379-387.
199. Wust S., Van Rossum E.F., Federenko I.S., Koper J.W., Kumsta R., Hellhammer D.H. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab. 2004, 89:565-573.
200. Wyrwoll C.S., Holmes M.C., Seckl J.R. 11beta-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front. Neuroendocrinol. 2011, 32:265-286.
201. Xie P., Kranzler H.R., Poling J., Stein M.B., Anton R.F., Farrer L.A., Gelernter J. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 2010, 35:1684-1692.
202. Xie P., Kranzler H.R., Yang C., Zhao H., Farrer L.A., Gelernter J. Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder. Biol. Psychiatry 2013, 74:656-663.
203. Yang N., Ray D.W., Matthews L.C. Current concepts in glucocorticoid resistance. Steroids 2012, 77:1041-1049.
204. Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann. N. Y. Acad. Sci. 2009, 1179:56-69.
205. Yehuda R., Bierer L.M. The relevance of epigenetics to PTSD: implications for the DSM-V. J. Trauma. Stress 2009, 22:427-434.
206. Yehuda R., Kahana B., Binder-Brynes K., Southwick S.M., Mason J.W., Giller E.L. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 1995, 152:982-986.
207. Yehuda R., Golier J.A., Halligan S.L., Meaney M., Bierer L.M. The ACTH response to dexamethasone in PTSD. Am. J. Psychiatry 2004, 161:1397-1403.
208. Yehuda R., Golier J.A., Yang R.K., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 2004, 55:1110-1116.
209. Yehuda R., Halligan S.L., Golier J.A., Grossman R., Bierer L.M. Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology 2004, 29:389-404.
210. Yehuda R., Cai G., Golier J.A., Sarapas C., Galea S., Ising M., Rein T., Schmeidler J., Muller-Myhsok B., Holsboer F., Buxbaum J.D. Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol. Psychiatry 2009, 66:708-711.
211. Yehuda R., Golier J.A., Bierer L.M., Mikhno A., Pratchett L.C., Burton C.L., Makotkine I., Devanand D.P., Pradhaban G., Harvey P.D., Mann J.J. Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PET. Psychiatry Res. 2010, 184:117-127.
212. Yehuda R., Daskalakis N.P., Desarnaud F., Makotkine I., Lehrner A.L., Koch E., Flory J.D., Buxbaum J.D., Meaney M.J., Bierer L.M. Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD. Front. Psychiatry 2013, 4:118.
213. Yehuda R., Daskalakis N.P., Lehrner A., Desarnaud F., Bader H.N., Makotkine I., Flory J.D., Bierer L.M., Meaney M.J. Influences of maternal and paternal PTSD on epigenetic regulation of the glucocorticoid receptor gene in Holocaust survivor offspring. Am. J. Psychiatry 2014, 171:872-880.
214. Yehuda R., Pratchett L.C., Elmes M.W., Lehrner A., Daskalakis N.P., Koch E., Makotkine I., Flory J.D., Bierer L.M. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus 2014, 4:20140048.
215. Yehuda R., Bierer L.M., Pratchett L.C., Lehrner A., Koch E.C., Van Manen J.A., Flory J.D., Makotkine I., Hildebrandt T. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology 2015, 51:589-597.
216. Yehuda R., Daskalakis N.P., Bierer L.M., Bader H.N., Klengel T., Holsboer F., Binder E.B. Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biol. Psychiatry 2015, http://dx.doi.10.1016/j.biopsych.2015.08.005.
217. Yehuda R., Flory J.D., Bierer L.M., Henn-Haase C., Lehrner A., Desarnaud F., Makotkine I., Daskalakis N.P., Marmar C.R., Meaney M.J. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol. Psychiatry 2015, 77:356-364.
218. Young E.A., Abelson J., Lightman S.L. Cortisol pulsatility and its role in stress regulation and health. Front. Neuroendocrinol. 2004, 25:69-76.
219. Zannas A.S., Provencal N., Binder E.B. Epigenetics of posttraumatic stress disorder: current evidence, challenges, and future directions. Biol. Psychiatry 2015, 78:327-335.
220. Zhang L., Zhou R., Li X., Ursano R.J., Li H. Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Med. Hypotheses 2006, 66:1205-1208.
221. Zohar J., Yahalom H., Kozlovsky N., Cwikel-Hamzany S., Matar M.A., Kaplan Z., Yehuda R., Cohen H. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies. Eur. Neuropsychopharmacol. 2011, 21:796-809.